Archive | September, 2006

British government defends new anti-ageist law

Clients from the UK should no longer call me saying they want to restructure their organization with some young energetic new blood. They would be breaking this new law. Suits me – forces the client to really think through what they really need. British government defends new anti-ageist law – Yahoo! News

Read full story Comments { 0 }

Invacare Reorganizes In The Second Largest Homecare Market – Germany

Invacare announced today that they were consolidating their sales organizations in the second largest homecare market in the world – Germany. The new organization will be known as Invacare Aquatec. Following the acquisition 2 years ago of Domus, the Aquatec and Invacare organizations in Germany had remained in separate locations (one in the north and [...]

Read full story Comments { 0 }

Oxygen equipment costs fuel debate in Ohio

The debate continues Oxygen equipment costs fuel debate in Ohio Medicare could buy almost 13 home oxygen machines for what it pays to rent one, according to a federal investigation.

Read full story Comments { 0 }

New Medicare Wheelchair Plan Could Hurt Pride – And Industry Update Prior to Medtrade 2006

Times Leader | 09/15/2006 | New Medicare wheelchair plan could hurt Pride Pennsylvania’s two U.S. senators and two local congressmen want to delay new, stricter Medicare policies they say might deny the elderly and disabled access to power wheelchairs. The new policies could also hurt wheelchair manufacturer Pride Mobility Products Corp., one of Luzerne County’s [...]

Read full story Comments { 1 }

FDA Statement on Coronary Drug-Eluting Stents

The FDA issued a statement September 14, 2006 following the controversy from papers presented at the presented at the March 2006 American College of Cardiology Scientific Sessions in Atlanta GA – (Basket-Late study) and more recently the Sept 2006 European Society of Cardiology Annual Meeting/World Congress of Cardiology Meeting in Barcelona Spain – (the Camenzind [...]

Read full story Comments { 0 }

NEJM — Sirolimus-Eluting versus Uncoated Stents in Acute Myocardial Infarction

The stent debate continues. NEJM — Sirolimus-Eluting versus Uncoated Stents in Acute Myocardial Infarction Background Sirolimus-eluting stents reduce rates of restenosis and reintervention, as compared with uncoated stents. Data are limited regarding the safety and efficacy of such stents in primary percutaneous coronary intervention (PCI) for acute myocardial infarction with ST-segment elevation.

Read full story Comments { 4 }

Chinese Medical Device Market – SeekingAlpha

This The Red Hot Market for Medical Devices in China – SeekingAlpha is an excellent article from Evelyn Rubin which reviews the IPO filing by Mindray – a medical device manufacturer with a substantial China presence. The filing contains a host of useful information on the Chinese medical products market.

Read full story Comments { 0 }

Who is my Customer? A Story of Achievment in Germany.

Again Germany could be a sample how to deal with the complexities of the rehab market sucessfully. If you take the right decision on the trivial question: Who is my customer? To identify your customer is one of the basics in marketing. You do a segmentation or you “enlarge your pond”, it is a daily [...]

Read full story Comments { 1 }